64
Participants
Start Date
March 31, 2013
Primary Completion Date
March 31, 2015
Study Completion Date
April 30, 2016
rigosertib
Oral rigosertib capsules at a dose of 560 mg twice a day for 14 consecutive days of a 21-day cycle (2 weeks on, 1 week off regimen).
Mount Sinai Medical Center, New York
Montefiore Medical Center, The Bronx
University of Pennslvania Abramson Cancer Center, Philadelphia
Virginia Cancer Specialists, PC, Fairfax
Blue Ridge Cancer Care, Salem
Ohio State University, James Cancer Hospital, Columbus
University of Michigan Health System, Ann Arbor
Mary Crowley Cancer Research Center, Dallas
University of Colorado School of Medicine, Aurora
Denver VA Medical Center-ECHCS, Denver
Stanford Cancer Institute, Stanford
University of California Davis Comprehensive Cancer Center, Sacramento
Veterans Administration New Jersey Health Care System, East Orange
Traws Pharma, Inc.
INDUSTRY